Home » Topics » BioWorld Science

BioWorld Science
RSS

MAP17 levels predict sensitivity of lung adenocarcinoma to chemotherapy

Sep. 3, 2018

FKBP5 strikes again: Gene variant affects risk of developing chronic pain after trauma

Sep. 3, 2018

Darzalex receives approval in Europe as treatment of newly diagnosed multiple myeloma

Sep. 3, 2018

Initial single-dose data presented from phase I study of NasoShield

Sep. 3, 2018

Phase I trial of Adverum's ADVM-022 gene therapy for wAMD to begin in Q4

Sep. 3, 2018

RegenxBio announces development of new candidate RGX-181 for CLN2 form of Batten disease

Sep. 3, 2018

Methylation of MORC1 predicts depression risk in humans

Sep. 3, 2018

HDAC inhibition can help in DNA repair syndrome

Sep. 3, 2018

Cannabis-schizophrenia association goes both ways, but unequally

Sep. 3, 2018

How cirrhosis drug fights Alzheimer's disease

Sep. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...